Greg Cohen
Impact in
-
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
-
- Liver Diseases and Immunity
Papers in
- Co-authors
- Loren Joseph (7 shared papers)Marc Bissonnette (7 shared papers)Sharad Khare (6 shared papers)Chris J. Norbury (1 shared paper)Marion MacFarlane (2 shared papers)Howard O. Fearnhead (1 shared paper)John Hart (5 shared papers)Sandra Cerda (4 shared papers)
- Journals
- Cancer Research (2 papers)Inflammatory Bowel Diseases (1 paper)Biochemical and Biophysical Research Communications (1 paper)European Journal of Cancer (1 paper)Gastroenterology (1 paper)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Greg Cohen
10 papers receiving 364 citations
Peers
Comparison fields: 5 of 54
- Oncology 165
- Hepatology 32
- Pharmacology 43
- Pathology and Forensic Medicine 44
- Cancer Research 36
Countries citing papers authored by Greg Cohen
This map shows the geographic impact of Greg Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Cohen more than expected).
Fields of papers citing papers by Greg Cohen
This network shows the impact of papers produced by Greg Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Cohen. The network helps show where Greg Cohen may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. | 2002 | 74 |
| 2 | 1994 | 62 | |
| 3 | Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. | 2003 | 52 |
| 4 | 2007 | 47 | |
| 5 | 2006 | 45 | |
| 6 | 2008 | 45 | |
| 7 | 2013 | 41 | |
| 8 | 1999 | 3 | |
| 9 | Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer | 2002 | 2 |
| 10 | 2003 | 1 |
About Greg Cohen
Greg Cohen is a scholar working on Oncology, Surgery, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 10 papers that have together received 372 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (3 papers), Inflammatory mediators and NSAID effects (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Estrogen and related hormone effects (1 paper), Epigenetics and DNA Methylation (1 paper) and Digestive system and related health (1 paper). The work is most often cited by research in Oncology (165 citations), Hepatology (32 citations), Pharmacology (43 citations), Pathology and Forensic Medicine (44 citations) and Cancer Research (36 citations). Greg Cohen has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Loren Joseph, Marc Bissonnette, Sharad Khare, Chris J. Norbury, Marion MacFarlane, Howard O. Fearnhead, John Hart, Sandra Cerda, Ramesh K. Wali and Urszula Dougherty. Their work appears in journals such as Cancer Research, Inflammatory Bowel Diseases, Biochemical and Biophysical Research Communications, European Journal of Cancer and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.